1409 ET - JPMorgan cut Kyndryl some slack last quarter when its revenue missed Wall Street expectations. No longer. "Today's negative guidance revision and stunning CFO change delays the turnaround, creating new questions across the thesis and forcing bulls to return to the drawing board," analysts write, downgrading the stock to underweight. They say that Kyndryl has stopped beating its profitability targets since the spin-off from IBM, and expect the stock to trade in line with DXC Technology until it can demonstrate greater upside. The search for a new CFO will be especially important to understand the outlook, they write. Kendryl plunges 54%.(elias.schisgall@wsj.com)
(END) Dow Jones Newswires
February 09, 2026 14:10 ET (19:10 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.